Skip to main content
Year archive

Genome&Company — 2026 filings

All 38 regulatory filings released by Genome&Company (314130) in 2026, sourced directly from the official regulator.

38 Filings
2026 Period
2026 filings (38)
Filing Released Lang
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Regulatory Filings
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Share Issue/Capital Change
2026-05-14 Korean
Regulatory Filings
2026-04-30 Korean
Share Issue/Capital Change
2026-04-28 Korean
Capital/Financing Update
2026-04-20 Korean
Share Issue/Capital Change
2026-04-13 Korean
Capital/Financing Update
2026-04-07 Korean
Share Issue/Capital Change
2026-04-03 Korean
Director's Dealing
2026-03-30 Korean
Director's Dealing
2026-03-30 Korean
Declaration of Voting Results & Voting Rights Announcements
2026-03-30 Korean
Board/Management Information
2026-03-30 Korean
Share Issue/Capital Change
2026-03-30 Korean
Share Issue/Capital Change
2026-03-30 Korean
Annual Report FY 2025
2026-03-20 Korean
Audit Report / Information FY 2025
2026-03-20 Korean
Share Issue/Capital Change
2026-03-13 Korean
Capital/Financing Update
2026-03-13 Korean
Proxy Solicitation & Information Statement
2026-03-13 Korean
Proxy Solicitation & Information Statement
2026-03-13 Korean
Proxy Solicitation & Information Statement
2026-03-13 Korean
AGM Information
2026-03-13 Korean
Capital/Financing Update
2026-03-06 Korean
Share Issue/Capital Change
2026-03-06 Korean
Earnings Release FY 2025
2026-02-23 Korean
Major Shareholding Notification
2026-01-30 Korean
Capital/Financing Update
2026-01-07 Korean
Major Shareholding Notification
2026-01-05 Korean